rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
2
|
pubmed:dateCreated |
2010-3-29
|
pubmed:abstractText |
We investigated the efficacy of gefitinib re-challenge for the patients who responded to initial treatment with gefitinib and acquired resistance to gefitinib thereafter.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
1872-8332
|
pubmed:author |
|
pubmed:copyrightInfo |
Copyright 2009 Elsevier Ireland Ltd. All rights reserved.
|
pubmed:issnType |
Electronic
|
pubmed:volume |
68
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
269-72
|
pubmed:meshHeading |
pubmed-meshheading:19660826-Adult,
pubmed-meshheading:19660826-Aged,
pubmed-meshheading:19660826-Antineoplastic Agents,
pubmed-meshheading:19660826-Carcinoma, Non-Small-Cell Lung,
pubmed-meshheading:19660826-Drug Resistance, Neoplasm,
pubmed-meshheading:19660826-Female,
pubmed-meshheading:19660826-Humans,
pubmed-meshheading:19660826-Lung Neoplasms,
pubmed-meshheading:19660826-Male,
pubmed-meshheading:19660826-Middle Aged,
pubmed-meshheading:19660826-Quinazolines,
pubmed-meshheading:19660826-Retrospective Studies,
pubmed-meshheading:19660826-Smoking,
pubmed-meshheading:19660826-Survival Analysis
|
pubmed:year |
2010
|
pubmed:articleTitle |
Effect of gefitinib re-challenge to initial gefitinib responder with non-small cell lung cancer followed by chemotherapy.
|
pubmed:affiliation |
Nishigunma Hospital, 2854 Kanai, Shibukawa, Gunma 377-8511, Japan. ytomizawa@netnngh.hosp.go.jp
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|